Alder BioPharmaceuticals: 2Q Earnings Snapshot
BOTHELL, Wash. (AP) _ Alder BioPharmaceuticals Inc. (ALDR) on Tuesday reported a loss of $58.4 million in its second quarter.
The Bothell, Washington-based company said it had a loss of 72 cents per share.
The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 99 cents per share.
Alder BioPharmaceuticals shares have declined 11% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $9.11, a decrease of 53% in the last 12 months.